ALKERMES | ALKS - PE Price to Earnings


ALKERMES reported 135.81 in PE Price to Earnings for its fiscal quarter ending in June of 2026.





Pe Change Date
AbbVie 23.96 0.93 Jun/2026
Acadia Pharmaceuticals 11.33 1.25 Jun/2026
ALKERMES 135.81 96.48 Jun/2026
Amgen 18.07 1.77 Jun/2026
Biogen 23.23 9.53 Jun/2026
BioMarin Pharmaceutical 21.07 5.79 Jun/2026
Bristol-Myers Squibb 16.14 7.06 Jun/2026
Eli Lilly 32.9 7.37 Jun/2026
Gilead Sciences 13.51 4.2 Jun/2026
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
J&J 29.43 4.9 Jun/2026
Malin Corporation 11.81 0.72 Jun/2023
Merck 32.26 15.74 Jun/2026
Neurocrine Biosciences 22.1 5.99 Jun/2026
Otsuka Holdings 13 1.31 Jun/2026
Ovoca Bio 1.83 3.29 Jun/2024
Pfizer 11.48 2.16 Jun/2026
Regeneron Pharmaceuticals 15.46 9.68 Jun/2026
Vertex Pharmaceuticals 28.05 2.22 Jun/2026